These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Diagnosis
601 results:

  • 1. Unveiling Melanoma: A Deep Dive into Disparities at a Latin-American Cancer Institute.
    Ziegler-Rodriguez G; De La Cruz-Ku G; Piedra-Delgado L; Torres-Maldonado J; Dunstan J; Cotrina-Concha JM; Galarreta-Zegarra JA; Calderon-Valencia G; Vilchez-Santillan S; Pinillos-Portella M; Möller MG
    Ann Surg Oncol; 2024 Sep; 31(9):6097-6117. PubMed ID: 38888862
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Effect of Socioeconomic Status and Race/Ethnicity on the Risk of Presenting With Advanced Stage at diagnosis in Embryonal tumors.
    Jung EM; Kitlinska JB; Johnson RA; Spector LG
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e259-e264. PubMed ID: 38691086
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study.
    Skaga E; Trewin-Nybråten CB; Niehusmann P; Johannesen TB; Marienhagen K; Oltedal L; Schipman S; Skjulsvik AJ; Solheim O; Solheim TS; Sundstrøm T; Vik-Mo EO; Petter Brandal ; Ingebrigtsen T
    Acta Oncol; 2024 Mar; 63():83-94. PubMed ID: 38501768
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas.
    Davison MA; Lilly DT; Patel AA; Kashkoush A; Chen X; Wei W; Benzel EC; Prayson RA; Chao S; Angelov L
    J Neurooncol; 2024 May; 167(3):437-446. PubMed ID: 38438766
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical Features and Outcomes of Black Patients With Melanoma.
    Wix SN; Brown AB; Heberton M; Adamson AS; Gill JG
    JAMA Dermatol; 2024 Mar; 160(3):328-333. PubMed ID: 38265787
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade.
    Li S; Tang T; Han J; Liu W; Chen R; Deng H; Jian T; Fu Z
    Cancer Epidemiol; 2024 Feb; 88():102515. PubMed ID: 38176331
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
    Yang Y; Yue C; Li Y; Piao Y
    Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Treatment Course and Outcomes of Intracranial Teratomas in Pediatric Patients: A Retrospective 15-Year Case Series Study.
    Wu A; Jin MC; Vogel H; Hiniker S; Campen C; Prolo LM; Grant GA
    Pediatr Neurosurg; 2023; 58(6):429-438. PubMed ID: 37879310
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
    Picart T; Pallud J; Berthiller J; Dumot C; Berhouma M; Ducray F; Armoiry X; Margier J; Guerre P; Varlet P; Meyronet D; Metellus P; Guyotat J;
    J Neurosurg; 2024 Apr; 140(4):987-1000. PubMed ID: 37856381
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preoperative differentiation of mediastinum and retroperitoneum ganglioneuroma from schwannoma with clinical data and enhanced CT: developing a multivariable prediction model.
    Lin Z; Feng Z
    Clin Radiol; 2023 Dec; 78(12):e925-e933. PubMed ID: 37833142
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
    Kotch C; Si SJ; Desai K; Caminada P; Lo Russo FM; Li Y; Liu GT; Avery RA; Fisher MJ
    J Neurooncol; 2023 Sep; 164(3):741-747. PubMed ID: 37803102
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Disparities in Primary Spinal Osseous Malignant Bone tumor Survival by Medicaid Status: A National Population-Based Risk Analysis.
    Ganga A; Kim EJ; Lee JY; Leary OP; Sastry RA; Fridley JS; Chang KE; Niu T; Sullivan PZ; Somasundar PS; Gokaslan ZL
    World Neurosurg; 2024 Jan; 181():e192-e202. PubMed ID: 37777175
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Delayed time to radiation and overall survival in Merkel cell carcinoma.
    Ma KL; Sharon CE; Tortorello GN; Keele L; Lukens JN; Karakousis GC; Miura JT
    J Surg Oncol; 2023 Dec; 128(8):1385-1393. PubMed ID: 37622232
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnostic accuracy of ultrasonography to distinguish thyroglossal duct cysts from dermoid cysts in children with a midline neck swelling.
    Eeftinck Schattenkerk LD; Lekkerkerker I; Hoekstra C; van Heurn LWE; Derikx JPM; Deurloo E
    Am J Otolaryngol; 2023; 44(5):103861. PubMed ID: 37454553
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pediatric Melanoma: Geographic Trends in Incidence, Stage, and Mortality in the United States.
    Borad A; Deianni E; Peña K; Burjonrappa S
    J Surg Res; 2023 Oct; 290():215-220. PubMed ID: 37285703
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Should Redo Surgery be Offered to Patients with Relapsed Glioblastoma? - Outcome Analyses of a Single Institution Comparative Cohort Study.
    Eltoukhy M; Kandula V; Joseph S; Albanese E; Giridharan S
    World Neurosurg; 2023 Aug; 176():e543-e547. PubMed ID: 37268188
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the german LGG studies.
    Weiß S; Thomale UW; Schulz M; Kandels D; Schuhmann MU; El Damaty A; Krauss J; Driever PH; Witt O; Bison B; Pietsch T; Gnekow A; Simon M
    Int J Cancer; 2023 Oct; 153(8):1487-1500. PubMed ID: 37260252
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
    Bender HG; Irwin MS; Hogarty MD; Castleberry R; Maris JM; Kao PC; Zhang FF; Naranjo A; Cohn SL; London WB
    J Clin Oncol; 2023 Jun; 41(17):3149-3159. PubMed ID: 37098238
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.
    Zhu P; Du XL; Hwang LY; Lairson D; Li R; Esquenazi Y; Zhu JJ
    Sci Rep; 2023 Feb; 13(1):3266. PubMed ID: 36841851
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Early-Stage Primary Lung Neuroendocrine tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.
    Oliver DE; Laborde JM; Singh DP; Milano MT; Videtic GM; Williams GR; LaRiviere MJ; Chan JW; Peters GW; Decker RH; Samson P; Robinson CG; Breen WG; Owen D; Tian S; Higgins KA; Almeldin D; Jabbour SK; Wang F; Grass GD; Perez BA; Dilling TJ; Strosberg J; Rosenberg SA
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):849-857. PubMed ID: 36708788
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 31.